Chest shielding in preterm neonates under phototherapy—a randomised control trial
- 19 August 2020
- journal article
- research article
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 180 (3) , 767-773
Abstract
Shielding the precordium can effect manifestation of haemodynamically significant patent ductus arteriosus (hsPDA). Preterm neonates born at ≤ 32 weeks of gestation if needed phototherapy within 72 h of birth and had no echocardiographically proven hsPDA were eligible to be enrolled in this open-label randomised controlled trial. In chest shielding group, in addition to the standard care, left side of the chest was covered using food grade aluminium foil during phototherapy while control group received standard care. Mean gestational age (weeks; 30.1 ± 1.5 vs 30.1 ± 1.6) was comparable in the two groups. However, neonates in the chest shield group had lower birth weight (g; 1281 ± 259 vs 1422 ± 307) and were more likely to be small-for-gestational age (21.6% vs 8.0%). It was seen that 4 (7.8%) babies in the chest shield group and 5 (10%) babies in the standard group developed hsPDA after starting phototherapy with relative risk (RR) of 0.78 (95% CI 0.22–2.75). The left atrium to aortic ratio was significantly different in the two groups with 1.5 ± 0.1 in the chest shield group and 1.8 ± 0.2 in standard group (p value 0.03). Conclusion: Chest shielding of preterm babies during phototherapy has no effect on the incidence of haemodynamically significant patent ductus arteriosus. Trial registration: Trial was registered with Clinical trial registry of India (CTRI/2018/01/011069). What is Known: • Chest shielding in preterm neonates under phototherapy has inconclusive effect on the manifestation of patent ductus arteriosus. What is New: • Preterm neonates under phototherapy have no significant difference in manifestation of haemodynamically significant patent ductus arteriosus if precordium is shielded.Keywords
This publication has 15 references indexed in Scilit:
- Paracetamol (acetaminophen) for patent ductus arteriosus in preterm or low-birth-weight infantsCochrane Database of Systematic Reviews, 2015
- An approach to the management of hyperbilirubinemia in the preterm infant less than 35 weeks of gestationJournal of Perinatology, 2012
- Patent ductus arteriosus in extremely preterm infants receiving phototherapy: Does shielding the chest make a difference? A randomized, controlled trialActa Paediatrica, 2006
- Placental and Other Perinatal Risk Factors for Chronic Lung Disease in Very Low Birth Weight InfantsPediatric Research, 2002
- Cardiac output and ductal reopening during phototherapy in preterm infantsActa Paediatrica, 1999
- The effect of phototherapy on cerebral blood flow velocity in preterm infantsActa Paediatrica, 1998
- Early ductal shunting and intraventricular haemorrhage in ventilated preterm infants.Archives of Disease in Childhood - Fetal and Neonatal Edition, 1996
- Dilatation of the ductus arteriosus by prostaglandin E1 in aortic arch abnormalities.Circulation, 1979
- Developmental Changes in Constriction of the Ductus Arteriosus: Responses to Oxygen and Vasoactive Agents in the Isolated Ductus Arteriosus of the Fetal LambPediatric Research, 1972
- The Photoactivated Relaxation of Smooth Muscle of Rabbit AortaJournal of General Physiology, 1961